Log in to save to my catalogue

Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's d...

Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's d...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6804616

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Trials in Alzheimer's disease (AD) now include participants at the earliest stages to prevent further decline. However, the lack of tools sensitive to subtle functional changes in early-stage AD hinders the development of new therapies as it is difficult to prove their clinical relevance.
We assessed functional changes over three years in 289 el...

Alternative Titles

Full title

Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6804616

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6804616

Other Identifiers

ISSN

2352-8737,1552-5260

E-ISSN

2352-8737,1552-5279

DOI

10.1016/j.trci.2019.08.009

How to access this item